Insider trades
Andrew Callos, Chief Officer of Cytokinetics CYTK, has filed 0 purchases and 31 sales on the open market. Over the past 12 months that comes to a net sale of $12.9M. The latest trade was on 06/01.
Andrew Callos
EVP, Chief Commercial Officer
- Company
- Cytokinetics CYTK
- First filing
- 23/02/17
- Trades
- 91 trades
- Buys / sales
- 0 / 31
- 12-month net buying
- −$12.9M
- Last trade
- 06/01
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
CytokineticsCYTK | Open-market sale10b5-1 plan | 06/01 | 06/01 | 15,000 sh | $74.08 | $1,111,200 | −20.4% |
CytokineticsCYTK | Open-market sale10b5-1 plan | 05/05 | 05/05 | 11,333 sh | $77.25 | $875,474.25 | −16.2% |
CytokineticsCYTK | Open-market sale10b5-1 plan | 05/01 | 05/04 | 15,857 sh | $65.00 | $1,030,705 | −21.3% |
CytokineticsCYTK | Open-market sale10b5-1 plan | 04/30 | 04/30 | 15,000 sh | $63.26 | $948,900 | −20.4% |
CytokineticsCYTK | Open-market sale10b5-1 plan | 04/15 | 04/15 | 7,449 sh | $66.02 | $491,782.98 | −11.3% |
CytokineticsCYTK | Open-market sale10b5-1 plan | 03/31 | 03/31 | 3,639 sh | $65.00 | $236,535 | −5.2% |
CYTK | Open-market sale10b5-1 plan | 03/17–03/18 | 03/18 | 10,472 sh3 trades | $62.14avg. | $650,680.4 | −11.8% |
CytokineticsCYTK | Open-market sale10b5-1 plan | 03/16 | 03/16 | 1,709 sh | $61.03 | $104,300.27 | −3.6% |
CytokineticsCYTK | Open-market sale | 03/09 | 03/10 | 2,582 sh | $60.72 | $156,779.04 | −5.1% |
CYTK | Open-market sale10b5-1 plan | 03/05 | 03/05 | 26,000 sh2 trades | $61.87avg. | $1,608,730 | −34.0% |
CytokineticsCYTK | Open-market sale10b5-1 plan | 03/02 | 03/02 | 886 sh | $61.62 | $54,595.32 | −1.7% |
CytokineticsCYTK | Open-market sale10b5-1 plan | 02/05 | 02/05 | 15,000 sh | $61.93 | $928,950 | −22.9% |
CytokineticsCYTK | Open-market sale10b5-1 plan | 02/02 | 02/02 | 886 sh | $62.10 | $55,020.6 | −1.7% |
CytokineticsCYTK | Open-market sale10b5-1 plan | 01/05 | 01/05 | 15,000 sh | $60.28 | $904,200 | −22.9% |
CYTK | Open-market sale10b5-1 plan | 01/02 | 01/02 | 1,798 sh2 trades | $62.62avg. | $112,584.77 | −3.4% |
CytokineticsCYTK | Open-market sale10b5-1 plan | 25/12/29 | 25/12/30 | 1,809 sh | $62.44 | $112,953.96 | −3.4% |
CytokineticsCYTK | Open-market sale10b5-1 plan | 25/12/08 | 25/12/08 | 1,042 sh | $65.96 | $68,730.32 | −2.0% |
CytokineticsCYTK | Open-market sale10b5-1 plan | 25/12/05 | 25/12/05 | 52,486 sh | $65.95 | $3,461,451.7 | −50.9% |
CytokineticsCYTK | Open-market sale10b5-1 plan | 25/06/05 | 25/06/05 | 8,659 sh | $32.04 | $277,434.36 | −14.3% |
CytokineticsCYTK | Open-market sale10b5-1 plan | 25/05/05 | 25/05/05 | 4,002 sh | $36.68 | $146,793.36 | −6.2% |